Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William B Tabayoyong

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cell Research|April 3, 2009
Meet the inlaws: embryonic stem cell derivatives meet the immune systemWilliam B Tabayoyong, Nicholas Zavazava
Leukemia Research|July 25, 2006
Soluble HLA revisitedWilliam B Tabayoyong, Nicholas Zavazava
Cancer|October 20, 2022
Evaluation of toxicities for intravesical drugs in phase 1 bladder cancer trialsKaren M Doersch, William B Tabayoyong, Jathin Bandari
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2009
HOXB4-transduced embryonic stem cell-derived Lin-c-kit+ and Lin-Sca-1+ hematopoietic progenitors express H60 and are targeted by NK cellsWilliam B Tabayoyong, Juan G Salas, Sabrina Bonde, et al.
Transplantation|December 24, 2008
HOXB4 but not BMP4 confers self-renewal properties to ES-derived hematopoietic progenitor cellsSabrina Bonde, Amy M Dowden, Kun-Ming Chan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2002
Reconstitution of lethally irradiated adult mice with dominant negative TGF-beta type II receptor-transduced bone marrow leads to myeloid expansion and inflammatory diseaseAli H Shah, William B Tabayoyong, Simon Y Kimm, et al.
European Urology|October 11, 2018
Prognostic Implication of the United States Food and Drug Administration-defined BCG-unresponsive DiseaseRoger Li, William B Tabayoyong, Charles C Guo, et al.
European Urology Focus|September 8, 2018
Systematic Review on the Utilization of Maintenance Intravesical Chemotherapy in the Management of Non-muscle-invasive Bladder CancerWilliam B Tabayoyong, Ashish M Kamat, Michael A O'Donnell, et al.
European Urology Oncology|June 16, 2019
Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not BenignRoger Li, Michael J Metcalfe, William B Tabayoyong, et al.
Cancer Research|December 25, 2002
Suppression of tumor metastasis by blockade of transforming growth factor beta signaling in bone marrow cells through a retroviral-mediated gene therapy in miceAli H Shah, William B Tabayoyong, Shilajit D Kundu, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cell Research|April 3, 2009
Meet the inlaws: embryonic stem cell derivatives meet the immune systemWilliam B Tabayoyong, Nicholas Zavazava
Leukemia Research|July 25, 2006
Soluble HLA revisitedWilliam B Tabayoyong, Nicholas Zavazava
Cancer|October 20, 2022
Evaluation of toxicities for intravesical drugs in phase 1 bladder cancer trialsKaren M Doersch, William B Tabayoyong, Jathin Bandari
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2009
HOXB4-transduced embryonic stem cell-derived Lin-c-kit+ and Lin-Sca-1+ hematopoietic progenitors express H60 and are targeted by NK cellsWilliam B Tabayoyong, Juan G Salas, Sabrina Bonde, et al.
Transplantation|December 24, 2008
HOXB4 but not BMP4 confers self-renewal properties to ES-derived hematopoietic progenitor cellsSabrina Bonde, Amy M Dowden, Kun-Ming Chan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2002
Reconstitution of lethally irradiated adult mice with dominant negative TGF-beta type II receptor-transduced bone marrow leads to myeloid expansion and inflammatory diseaseAli H Shah, William B Tabayoyong, Simon Y Kimm, et al.
European Urology|October 11, 2018
Prognostic Implication of the United States Food and Drug Administration-defined BCG-unresponsive DiseaseRoger Li, William B Tabayoyong, Charles C Guo, et al.
European Urology Focus|September 8, 2018
Systematic Review on the Utilization of Maintenance Intravesical Chemotherapy in the Management of Non-muscle-invasive Bladder CancerWilliam B Tabayoyong, Ashish M Kamat, Michael A O'Donnell, et al.
European Urology Oncology|June 16, 2019
Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not BenignRoger Li, Michael J Metcalfe, William B Tabayoyong, et al.
Cancer Research|December 25, 2002
Suppression of tumor metastasis by blockade of transforming growth factor beta signaling in bone marrow cells through a retroviral-mediated gene therapy in miceAli H Shah, William B Tabayoyong, Shilajit D Kundu, et al.
Pageof 1